Is This Stock a Screaming Buy: Dermira, Inc. (NASDAQ:DERM)

Equity Research firms currently have a positive stance on shares of Dermira, Inc. (NASDAQ:DERM). The majority of analysts covering the equity have a consensus Strong Buy recommendation on the stock, yielding a score of 1.40. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $44.33 on a short term basis.

At the time of writing, the stock was trading at $34.84. This represents a change from the opening price of -0.23%. In terms of performance, year to date, the stock is 0.92%. The monthly stock performance comes in at 5.62%. For the quarter, shares are performing at 13.01%. Weekly performance analysis shows the equity at 6.92%.

In taking a look at technical levels, shares are trading 5.98% away from the 50 day simple moving average and 22.09% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -3.65% away from it’s 52- week high and 100.00% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, Dermira, Inc.’s RSI stands at 58.28. In looking at volatility levels, the shares saw weekly volatility of 3.90% and 3.96% over the past month.

Leave a Comment